Neuropathology
Seyed Abbas Tabatabaei Yazdi; Masoomeh Safaei; Mehran Gholamin; Alireza Abdollahi; Fatemeh Nili; Mehdi Jabbari Nooghabi; Kazem Anvari; Majid Mojarrad
Abstract
Background & Objectives: Glioblastoma is the most common primary malignancy of the brain, the prognosis of which is poor. Immunotherapy with cancer/testis (CT) antigens is a novel therapeutic approach for glioblastoma. This study aimed to investigate the expression rate of MAGE-E1, GAGE, and SOX-6 ...
Read More
Background & Objectives: Glioblastoma is the most common primary malignancy of the brain, the prognosis of which is poor. Immunotherapy with cancer/testis (CT) antigens is a novel therapeutic approach for glioblastoma. This study aimed to investigate the expression rate of MAGE-E1, GAGE, and SOX-6 in glioblastoma tumors using the immunohistochemistry (IHC) method. Materials & Methods: Expression of MAGE-E1, GAGE, and SOX-6 were determined by IHC in 50 paraffin blocks of glioblastoma. The results were compared between variables including age, gender, tumor location, and Karnofsky performance status (Kps) score. Survival analysis was also performed. Results: The expression levels of SOX-6, MAGE-E1, and GAGE were 82%, 78%, and 76%, respectively. The relationship between CT antigens and age, gender, and tumor location was not significant, while the association between MAGE-E1 expression and age was statistically significant (p =0.002). High expression levels of SOX-6 and MAGE-E1 were associated with low Kps scores (p =0.034 and p <0.001, respectively). Survival analysis showed that age >40 and Kps score p =0.005 and p =0.018, respectively). Expression of MAGE-E1 and GAGE was negatively associated with overall 2-year survival (p =0.001 and p =0.021, respectively). Conclusion: The expression of all the three CT antigens, especially MAGE-E1 and SOX-6, was high in patients with glioblastoma. It can be concluded that these markers are ideal targets for immunotherapy in these patients. MAGE-E1 and SOX-6 can be considered as important markers in determining the prognosis of glioblastoma.
Seyed Abbass Tabatabaei Yazdi; Alireza Rezaei; Jafar Bordbar Azari; Aria Hejazi; Mohammad Taghi Shakeri; Mahdi Karimi Shahri
Volume 4, Issue 3 , June 2009, , Pages 101-104
Abstract
Background and Objective: Ischemic heart disease (IHD) following atherosclerosis is the most common cause of cardiac deaths world wide. We aimed to investigate the pathologic features of atherosclerosis in non cardiac death cases to have an estimate of atherosclerosis prevalence in Mashad (North ...
Read More
Background and Objective: Ischemic heart disease (IHD) following atherosclerosis is the most common cause of cardiac deaths world wide. We aimed to investigate the pathologic features of atherosclerosis in non cardiac death cases to have an estimate of atherosclerosis prevalence in Mashad (North east of Iran). Patients and Methods : This descriptive (cross sectional) study was done, during October 2007 – March 2008, on 80 cadavers from 11 to 50 years old who had died of non cardiac causes and had no history of cardiac disease. After autopsy in forensic medical center, coronary arteries were removed and examined for atherosclerotic plaques. In case of a definite or suspicious lesion, microscopic slides were also prepared. Otherwise, three random slides from each branch of coronary arteries were studied by a pathologist. Results: We found that 73.1% of men and 61.5% of women had at least one fibrofatty or advanced plaque in major coronary arteries. Atherosclerosis in 41.8% of men and 30.8% of women was in advanced form. Frequency of advanced atherosclerotic plaques progressed with age reaching a maximum of 78.5% by the age of 41-50 years. In addition, prevalence of plaques suddenly increased after second decade of life. Atherosclerotic plaques were most commonly found in left anterior descending artery (60%) followed by right coronary (50%) and left circumflex (42.5%) arteries. Conclusion: This study showed an unexpectedly high prevalence of atherosclerosis in this population. It highlights the importance of cardiovascular risk factor screening from early ages of third decade.
